Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T14:16:14.221Z.
Calculation as of: 2026-10-06T14:16:14.221Z.
Quote observation: 2026-10-06T14:15:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ea268c636d02c1563f9a0cc17fa45ef3048b6802d4031696aa30e1bc9d7aaf2a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Connect Biopharma Holdings Limited
Market Cap
$56.29M
EV/FCF Ratio
N/A
| NAME | MARKET CAP | EV/FCF RATIO |
|---|---|---|
| Connect Biopharma Holdings Limited (CNTB) | $56.29M | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $55.97M | N/A |
| Spectral AI, Inc. (MDAI)vs › | $55.53M | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $57.31M | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $54.14M | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $58.57M | N/A |
| Aldeyra The (ALDX)vs › | $58.80M | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.84M | N/A |
| Apollomics, Inc. (APLM)vs › | $53.17M | N/A |
| ImageneBio Inc (IMA)vs › | $53.01M | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
